Evidence map›Paper›PMID 40189728›Full record

ArticleMedical & biological engineering & computing2025

Enhancing breast cancer diagnosis: transfer learning on DenseNet with neural hashing for histopathology fine-grained image classification.

Fatemeh Taheri, Kambiz Rahbar

Abstract read
PubMed Publisher
In one paragraph

Article in Medical & biological engineering & computing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Fatemeh TaheriDepartment of Computer Engineering, ST.C., Islamic Azad University, Tehran, Iran.
Kambiz RahbarDepartment of Computer Engineering, ST.C., Islamic Azad University, Tehran, Iran. kambiz.rahbar@iau.ac.ir.ORCID http://orcid.org/0000-0003-2212-0479

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is one of the most common types of cancer worldwide. The number of breast cancer cases highlights the importance of disease management at various levels. One complementary method for breast cancer classification is microscopic imaging. Manual histopathological image analysis is time-consuming and prone to human errors. Computer-aided diagnosis (CAD) has emerged as a popular and feasible solution for analyzing medical images due to extensive advancements. Microscopic image analysis can assist physicians in more accurate diagnosis. However, the performance of CAD models needs improvement for practical purposes. In the proposed approach, a baseline model called DenseNet is considered for extracting features from histopathological images. The pre-trained DenseNet model alone is not sufficient for fine-grained feature discrimination between benign and malignant histopathological image samples. Therefore, two hash layers are incorporated at the end of the network to enhance feature separability of the two classes, benign and malignant. The performance of the proposed method is evaluated on the BreakHis histopathological image dataset, with magnifications of 40 × , 100 × , 200 × , and 400 × . The evaluation results confirm the effectiveness of the proposed approach compared to other existing approaches. Furthermore, the interpretability of the proposed approach is demonstrated using the LIME technique.

Indexed as

Breast NeoplasmsDiagnosis, Computer-AssistedImage Interpretation, Computer-AssistedImage Processing, Computer-AssistedMachine LearningNeural Networks, ComputerAlgorithmsConvolutional Neural NetworksFemaleHumansDenseNet networkFine-grained breast cancer classificationHash neural modelHistopathological images

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.